110 related articles for article (PubMed ID: 17543985)
1. Differential effects of phosphorylation on DNA binding properties of N Oct-3 are dictated by protein/DNA complex structures.
Nieto L; Joseph G; Stella A; Henri P; Burlet-Schiltz O; Monsarrat B; Clottes E; Erard M
J Mol Biol; 2007 Jul; 370(4):687-700. PubMed ID: 17543985
[TBL] [Abstract][Full Text] [Related]
2. Solution structure of the POU-specific DNA-binding domain of Oct-1.
Dekker N; Cox M; Boelens R; Verrijzer CP; van der Vliet PC; Kaptein R
Nature; 1993 Apr; 362(6423):852-5. PubMed ID: 8479524
[TBL] [Abstract][Full Text] [Related]
3. Linker length and composition influence the flexibility of Oct-1 DNA binding.
van Leeuwen HC; Strating MJ; Rensen M; de Laat W; van der Vliet PC
EMBO J; 1997 Apr; 16(8):2043-53. PubMed ID: 9155030
[TBL] [Abstract][Full Text] [Related]
4. Fine-tuning of intrinsic N-Oct-3 POU domain allostery by regulatory DNA targets.
Alazard R; Mourey L; Ebel C; Konarev PV; Petoukhov MV; Svergun DI; Erard M
Nucleic Acids Res; 2007; 35(13):4420-32. PubMed ID: 17576670
[TBL] [Abstract][Full Text] [Related]
5. Expression and purification of human full-length N Oct-3, a transcription factor involved in melanoma growth.
Cabos-Siguier B; Steunou AL; Joseph G; Alazard R; Ducoux-Petit M; Nieto L; Monsarrat B; Erard M; Clottes E
Protein Expr Purif; 2009 Mar; 64(1):39-46. PubMed ID: 18996486
[TBL] [Abstract][Full Text] [Related]
6. The POU domain is a bipartite DNA-binding structure.
Sturm RA; Herr W
Nature; 1988 Dec; 336(6199):601-4. PubMed ID: 2904656
[TBL] [Abstract][Full Text] [Related]
7. Oct-1 enhances the in vitro replication of a mammalian autonomously replicating DNA sequence.
Matheos DD; Ruiz MT; Price GB; Zannis-Hadjopoulos M
J Cell Biochem; 1998 Mar; 68(3):309-27. PubMed ID: 9518258
[TBL] [Abstract][Full Text] [Related]
8. Activator recruitment by the general transcription machinery: X-ray structural analysis of the Oct-1 POU domain/human U1 octamer/SNAP190 peptide ternary complex.
Hovde S; Hinkley CS; Strong K; Brooks A; Gu L; Henry RW; Geiger J
Genes Dev; 2002 Nov; 16(21):2772-7. PubMed ID: 12414730
[TBL] [Abstract][Full Text] [Related]
9. Modeling and analysis of MH1 domain of Smads and their interaction with promoter DNA sequence motif.
Makkar P; Metpally RP; Sangadala S; Reddy BV
J Mol Graph Model; 2009 Apr; 27(7):803-12. PubMed ID: 19157940
[TBL] [Abstract][Full Text] [Related]
10. Identification of DPPA4 and other genes as putative Sox2:Oct-3/4 target genes using a combination of in silico analysis and transcription-based assays.
Chakravarthy H; Boer B; Desler M; Mallanna SK; McKeithan TW; Rizzino A
J Cell Physiol; 2008 Sep; 216(3):651-62. PubMed ID: 18366076
[TBL] [Abstract][Full Text] [Related]
11. Characteristic patterns of N Oct-3 binding to a set of neuronal promoters.
Blaud M; Vossen C; Joseph G; Alazard R; Erard M; Nieto L
J Mol Biol; 2004 Jun; 339(5):1049-58. PubMed ID: 15178247
[TBL] [Abstract][Full Text] [Related]
12. Characterization of two POU transcription factor family members from the urochordate Oikopleura dioica.
Cupit PM; Lennard ML; Hikima J; Warr GW; Cunningham C
Gene; 2006 Nov; 383():1-11. PubMed ID: 16989962
[TBL] [Abstract][Full Text] [Related]
13. Structure of the human FOXO4-DBD-DNA complex at 1.9 Å resolution reveals new details of FOXO binding to the DNA.
Boura E; Rezabkova L; Brynda J; Obsilova V; Obsil T
Acta Crystallogr D Biol Crystallogr; 2010 Dec; 66(Pt 12):1351-7. PubMed ID: 21123876
[TBL] [Abstract][Full Text] [Related]
14. Use of altered-specificity binding Oct-4 suggests an absence of pluripotent cell-specific cofactor usage.
Smith AE; Ford KG
Nucleic Acids Res; 2005; 33(18):6011-23. PubMed ID: 16243786
[TBL] [Abstract][Full Text] [Related]
15. Characterization of the DNA-binding properties and the transactivation activity of Schistosoma mansoni nuclear receptor fushi tarazu-factor 1alpha (SmFTZ-F1alpha).
Lu C; Niles EG; LoVerde PT
Mol Biochem Parasitol; 2006 Nov; 150(1):72-82. PubMed ID: 16890303
[TBL] [Abstract][Full Text] [Related]
16. Oct-2 DNA binding transcription factor: functional consequences of phosphorylation and glycosylation.
Ahmad I; Hoessli DC; Walker-Nasir E; Rafik SM; Shakoori AR; Nasir-ud-Din
Nucleic Acids Res; 2006; 34(1):175-84. PubMed ID: 16431844
[TBL] [Abstract][Full Text] [Related]
17. Protein kinase A phosphorylates serine 267 in the homeodomain of engrailed-2 leading to decreased DNA binding.
Hjerrild M; Stensballe A; Jensen ON; Gammeltoft S; Rasmussen TE
FEBS Lett; 2004 Jun; 568(1-3):55-9. PubMed ID: 15196920
[TBL] [Abstract][Full Text] [Related]
18. DNA-PK phosphorylation sites on Oct-1 promote cell survival following DNA damage.
Schild-Poulter C; Shih A; Tantin D; Yarymowich NC; Soubeyrand S; Sharp PA; Haché RJ
Oncogene; 2007 Jun; 26(27):3980-8. PubMed ID: 17213819
[TBL] [Abstract][Full Text] [Related]
19. Regulation of the immunoglobulin heavy chain locus expression at the phylogenetic level of a bony fish: transcription factor interaction with two variant octamer motifs.
Hikima J; Lennard ML; Wilson MR; Miller NW; Warr GW
Gene; 2006 Aug; 377():119-29. PubMed ID: 16759823
[TBL] [Abstract][Full Text] [Related]
20. Identification of the 'NORE' (N-Oct-3 responsive element), a novel structural motif and composite element.
Alazard R; Blaud M; Elbaz S; Vossen C; Icre G; Joseph G; Nieto L; Erard M
Nucleic Acids Res; 2005; 33(5):1513-23. PubMed ID: 15767276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
